KN5501
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KN5501, covering 2025-04-30 to 2025-04-30. Get the full timeline:
Most recent: Clinical Trial Update: An Exploratory Clinical Study of Anti-CD19 CAR NK Cell (KN5501) in the Treatment of Relapsed/Refractory Immune Nephropathy [EARLY_Phase 1]